The FDA has designated Morphochem’s MCB3837 as a Qualified Infectious Disease Product and simultaneously put the antibiotic on its regulatory fast-track…

Biogen's CEO steps down, Theranos brings on a team to right its wrongs and FDA's Hall leaves for PatientsLikeMe. Plus more hirings, firings and…

This week an FDA panel backed Valeant's skin drug brodalumab and then the regulator gave the thumbs up for an oral version of its constipation drug…

Initially it looked like a U.S. biotech to be the first; then a team funded by the billionaire co-founder of Napster; now, it looks like it will be Chinese…

InflaRx has raised $34 million in a Series C to at least get it through Phase II testing for its lead candidate, as well as to expand its preclinical pipeline.

Fresh off a positive FDA panel earlier this month for what could be its first approved biosimilar for Humira, Amgen--and partner Allergan--have reported…

In our EuroBiotech roundup this week, PamBio raises $7 million for stroke R&D, Pharming shares jump on Phase II data and Hookipa starts cytomegalovirus…

Brexit rejig leaves the U.K. without a life science minister, Shire takes a stake in Chronos, Poxel postpones its IPO and more.